Kidney cancer, Renal cell cancer
Results
Phase 2
This trial looked at a biological therapy drug called lenvatinib for kidney cancer that had spread to another part of the body. It was for people whose first treatment had stopped working.
Recruitment start: 16 March 2012
Recruitment end: 19 June 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr James Larkin
Eisai
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer’
Last reviewed: 31 Jul 2016
CRUK internal database number: 9148
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
